Markets.News
ELI LILLY ANNOUNCES THAT QUALIFIED MEDICARE PART D PATIENTS COULD ACCESS FOUNDAYO FOR $50 A MONTH STARTING JULY 1, 2026. COMBINING FOUNDAYO WITH OTHER GLP-1 RECEPTOR AGONISTS IS NOT ADVISED.